Alex Dodoo

766 total citations
14 papers, 406 citations indexed

About

Alex Dodoo is a scholar working on Toxicology, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Alex Dodoo has authored 14 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Toxicology, 6 papers in Public Health, Environmental and Occupational Health and 6 papers in Economics and Econometrics. Recurrent topics in Alex Dodoo's work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Pharmaceutical Economics and Policy (5 papers) and Pharmaceutical Quality and Counterfeiting (4 papers). Alex Dodoo is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (6 papers), Pharmaceutical Economics and Policy (5 papers) and Pharmaceutical Quality and Counterfeiting (4 papers). Alex Dodoo collaborates with scholars based in Ghana, Switzerland and United States. Alex Dodoo's co-authors include Sten Olsson, Shanthi Pal, Mahama Duwiejua, Hannes Enlund, Lloyd Matowe, Patrick Imbert, Fabrice Legros, Martin Danis, Olivier Bouchaud and C. Burri and has published in prestigious journals such as PLoS ONE, American Journal of Public Health and PLoS Medicine.

In The Last Decade

Alex Dodoo

14 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Dodoo Ghana 10 138 131 91 84 78 14 406
Priya Bahri Netherlands 14 46 0.3× 128 1.0× 64 0.7× 120 1.4× 75 1.0× 30 437
Kenneth Hartigan‐Go Philippines 12 65 0.5× 68 0.5× 117 1.3× 46 0.5× 164 2.1× 35 526
Gurumurthy Parthasarathi India 13 45 0.3× 118 0.9× 63 0.7× 65 0.8× 24 0.3× 32 467
Mary Couper Switzerland 8 77 0.6× 199 1.5× 40 0.4× 133 1.6× 19 0.2× 9 451
Kim Ward South Africa 10 87 0.6× 30 0.2× 46 0.5× 180 2.1× 15 0.2× 17 333
François Houÿez France 8 44 0.3× 91 0.7× 57 0.6× 48 0.6× 11 0.1× 22 272
Jude Nwokike United States 10 136 1.0× 27 0.2× 32 0.4× 124 1.5× 11 0.1× 19 289
Prasad Thota India 12 33 0.2× 114 0.9× 118 1.3× 30 0.4× 7 0.1× 32 336
Mira Desai India 12 48 0.3× 58 0.4× 135 1.5× 29 0.3× 5 0.1× 41 403
Jorge Díaz Colombia 11 32 0.2× 27 0.2× 19 0.2× 36 0.4× 22 0.3× 54 328

Countries citing papers authored by Alex Dodoo

Since Specialization
Citations

This map shows the geographic impact of Alex Dodoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Dodoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Dodoo more than expected).

Fields of papers citing papers by Alex Dodoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Dodoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Dodoo. The network helps show where Alex Dodoo may publish in the future.

Co-authorship network of co-authors of Alex Dodoo

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Dodoo. A scholar is included among the top collaborators of Alex Dodoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Dodoo. Alex Dodoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Aborigo, Raymond, et al.. (2022). Optimising reporting of adverse events following immunisation by healthcare workers in Ghana: A qualitative study in four regions. PLoS ONE. 17(12). e0277197–e0277197. 7 indexed citations
3.
Gidudu, Jane, Alex Dodoo, Samuel Bosomprah, et al.. (2019). Barriers to healthcare workers reporting adverse events following immunization in four regions of Ghana. Vaccine. 38(5). 1009–1014. 23 indexed citations
4.
5.
Rosenkranz, Bernd, Elizabeth Allen, Jacques Demotes‐Mainard, et al.. (2015). Education and training for medicines development, regulation, and clinical research in emerging countries. Frontiers in Pharmacology. 6. 80–80. 11 indexed citations
6.
Choonara, Imti, et al.. (2015). Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase. Expert Opinion on Drug Safety. 14(12). 1827–1833. 8 indexed citations
7.
Olsson, Sten, Shanthi Pal, & Alex Dodoo. (2015). Pharmacovigilance in resource-limited countries. Expert Review of Clinical Pharmacology. 8(4). 449–460. 103 indexed citations
8.
9.
Bakare, Nyasha, I. Ralph Edwards, Andy Stergachis, et al.. (2011). Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. PLoS Medicine. 8(7). e1001054–e1001054. 16 indexed citations
10.
Bouchaud, Olivier, et al.. (2009). Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base. Malaria Journal. 8(1). 289–289. 48 indexed citations
11.
Ofori‐Adjei, David, et al.. (2008). A review of the safety of niclosamide, pyrantel, triclabendazole and oxamniquine. International Journal of Risk & Safety in Medicine. 20(3). 113–122. 17 indexed citations
12.
Duwiejua, Mahama, et al.. (2007). Self-reported use of anti-malarial drugs and health facility management of malaria in Ghana. Malaria Journal. 6(1). 85–85. 52 indexed citations
13.
Dodoo, Alex, et al.. (2007). Intensive Monitoring of Adverse Events (AE) to Antiretroviral Drugs (ARV) in Ghana. Drug Safety. 30(10). 919–990. 1 indexed citations
14.
Folb, Peter I., Ewa Bernatowska, Robert Chen, et al.. (2004). A Global Perspective on Vaccine Safety and Public Health: The Global Advisory Committee on Vaccine Safety. American Journal of Public Health. 94(11). 1926–1931. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priya Bahri Breakdown of academic impact, for papers by Kenneth Hartigan‐Go Breakdown of academic impact, for papers by Gurumurthy Parthasarathi Breakdown of academic impact, for papers by Mary Couper Breakdown of academic impact, for papers by Kim Ward Breakdown of academic impact, for papers by François Houÿez Breakdown of academic impact, for papers by Jude Nwokike Breakdown of academic impact, for papers by Prasad Thota Breakdown of academic impact, for papers by Mira Desai Breakdown of academic impact, for papers by Jorge Díaz
Rankless by CCL
2026